Cargando…
Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy
INTRODUCTION: Glucocorticoid-induced osteoporosis is an underrecognized complication of chronic glucocorticoid therapy characterized by a decrease in new bone formation. Anabolic therapies, such as teriparatide, a recombinant human parathyroid hormone, combat the disease by promoting new bone growth...
Autores principales: | Taylor, Adam D, Saag, Kenneth G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711555/ https://www.ncbi.nlm.nih.gov/pubmed/31692480 http://dx.doi.org/10.2147/CE.S172820 |
Ejemplares similares
-
Anabolic therapy for osteoporosis: update on efficacy and safety
por: Bandeira, Leonardo, et al.
Publicado: (2022) -
Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis
por: Dore, Robin K
Publicado: (2013) -
Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015) -
Glucocorticoid-induced osteoporosis: from clinical trials to clinical
practice
por: Adami, Giovanni, et al.
Publicado: (2019) -
A review of anabolic therapies for osteoporosis
por: Lane, Nancy E, et al.
Publicado: (2003)